Skip to main content
Year archive

ChoA Pharmaceutical Co., LTD. — 2020 filings

All 21 regulatory filings released by ChoA Pharmaceutical Co., LTD. (034940) in 2020, sourced directly from the official regulator.

21 Filings
2020 Period
2020 filings (21)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-16 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-16 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-07-10 Korean
불성실공시법인지정(공시불이행)
Regulatory Filings
2020-05-28 Korean
전환청구권행사
Share Issue/Capital Change
2020-05-19 Korean
전환청구권행사
Share Issue/Capital Change
2020-05-18 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
불성실공시법인지정예고(공시불이행)
Regulatory Filings
2020-05-07 Korean
투자판단관련주요경영사항(저반응성난소군 난임 여성을 대상으로 작약복합추출물(CHOA_PLCR)의 제2상A 임상시험계획승인)
Regulatory Filings
2020-04-24 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제3회차)
Capital/Financing Update
2020-04-24 Korean
사업보고서 (2019.12)
Audit Report / Information FY 2019
2020-03-30 Korean
전환가액의조정
Capital/Financing Update
2020-03-24 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-24 Korean
감사보고서제출
Regulatory Filings
2020-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-05 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-02-27 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-02-24 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-02-24 Korean
전환청구권행사(제3회차)
Share Issue/Capital Change
2020-02-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-01-22 Korean